As TGFβ/Smad pathways are central mediators of signals from the receptors for TGFβ superfamily members to the nucleus, we first assessed the effect of SMC4 modulation on Smad transcriptional activity in glioma cells by using a Smad reporter luciferase activity assay. The gene discussed is SMC4; the disease is central nervous system cancer.